RusnanoMedInvest, Domain Associates and investor syndicate back ReVision Optics vision correction technology with $55 mln investment

02 August 2013

RusnanoMedInvest invested in American technology for vision correction

Venture News

American venture Fund Domain Associates, venture investment company RusnanoMedInvest (RMI, affiliate of ROSNANO) and a group of co-investors invest $55M in the company ReVision Optics, Inc., which develops innovation medical technology for treatment of age-dependent visual acuity decrement.

31 July 2013

As ReVision Raises $55M, Domain’s Brian Dovey Assesses Rusnano Gambit

Bruce V. Bigelow, Xconomy

Almost 18 months ago, Domain Associates and the Russian state technology firm Rusnano agreed to jointly invest as much as $760 million in life sciences deals in the U.S. and Russia. Yesterday, the partners said they have completed their fifth deal—joining a $55 million equity round in ReVision Optics, a Lake Forest, CA-ophthalmic company.

30 July 2013

Rusnano Invests With U.S. Venture Fund

The Moscow Times

Rusnano subsidiary RusnanoMednvest and U.S. venture fund Domain Associates have joined a consortium investing $55 million in the U.S. firm ReVision Optics, which is developing technologies to treat age-related vision loss, Interfax reported.

30 July 2013

Domain, Rusnano invest in ReVision

BioCentury

Domain Associates and Rusnano, the state-funded $10 billion Russian fund, made their fifth investment under a 2012 investment partnership in Domain portfolio company ReVision Optics Inc. (Lake Forest, Calif.). 

30 July 2013

J&J buys into ReVision Optics' $55M financing round

Mark Hollmer, FierceMedicalDevices

ReVision Optics attracted an impressive $55 million in new equity financing from the likes of Johnson & Johnson ($JNJ) and a Russian investor group--a massive cash infusion that will advance its hydrogel eye implant designed to help reduce the need for reading glasses.